NEU 0.61% $19.82 neuren pharmaceuticals limited

I agree. I wouldn't sell at these prices even if we didn't have...

  1. 1,431 Posts.
    lightbulb Created with Sketch. 93
    I agree. I wouldn't sell at these prices even if we didn't have NNZ-2256!

    Daybue guidance (70m AUD) on a 40 forward PE = 2.8B AUD. We also have 250m cash on top of this. Zero value assigned to NNZ-2256

    This 40 forward PE is very reasonable because:

    • Peak sales won't be achieved in the first full year, so there will be growth in the coming years (North America)
    • Additional geographies will add more sales, even if the pricing isn't as strong as North America (Europe and Japan, EMA)
    • Milestone payments aren't included in my calculations, but they go straight to earnings. These milestones are reasonable and many of them can be hit within a reasonable time frame. An additional 77m~ is projected to be comfortably hit based on the guidance already provided.
    • PRV isn't included in these calculations.
    • We have very low expenses compared to peers and, our expenses spent on R&D are partially a tax deduction.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.82
Change
0.120(0.61%)
Mkt cap ! $2.530B
Open High Low Value Volume
$19.80 $19.82 $18.85 $6.333M 324.6K

Buyers (Bids)

No. Vol. Price($)
1 30 $19.70
 

Sellers (Offers)

Price($) Vol. No.
$19.83 1160 2
View Market Depth
Last trade - 16.10pm 06/05/2024 (20 minute delay) ?
Last
$19.74
  Change
0.120 ( 0.07 %)
Open High Low Volume
$19.76 $19.80 $18.86 101075
Last updated 15.59pm 06/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.